Regulation of ERK1/2 by ouabain and Na-K-ATPase-dependent energy utilization and AMPK activation in parotid acinar cells
Division of Signal Transduction, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts Submitted 31 March 2008 ; accepted in final form 21 July 2008 We previously found that the phosphorylation of ERK1/2 by submaximal concentrations of the muscarinic receptor ligand car...
Gespeichert in:
Veröffentlicht in: | American Journal of Physiology: Cell Physiology 2008-09, Vol.295 (3), p.C590-C599 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Division of Signal Transduction, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts
Submitted 31 March 2008
; accepted in final form 21 July 2008
We previously found that the phosphorylation of ERK1/2 by submaximal concentrations of the muscarinic receptor ligand carbachol was potentiated in rat parotid acinar cells exposed to ouabain, a cardiac glycoside that inhibits the Na-K-ATPase. We now report that this signaling phenomenon involves the prevention of negative regulation of extracellular signal-regulated kinase-1/2 (ERK1/2) that is normally mediated by AMP-activated protein kinase (AMPK). Carbachol increases the turnover of the ATP-consuming Na-K-ATPase, reducing intracellular ATP and promoting the phosphorylation/activation of the energy sensor AMPK. Ouabain blocks the reduction in ATP and subsequent AMPK phosphorylation, which is regulated by the AMP-to-ATP ratio. The ouabain-promoted enhancement of ERK1/2 phosphorylation was not reproduced in Par-C10 cells, an immortalized rat parotid cell line that did not respond to carbachol with an ATP reduction and that employs an upstream AMPK kinase (Ca 2+ /calmodulin-dependent protein kinase kinase, CaMKK) different from that (LKB1) in native cells. In native parotid cells, inhibitory effects of AMPK on ERK1/2 signaling were examined by activating AMPK with 5-aminoimidazole-4-carboxamide-1-β- D -ribofuranoside (AICAR), which is converted to an AMP mimetic but does not alter parotid ATP levels. AICAR-treated cells display increases in AMPK phosphorylation and a reduced phosphorylation of ERK1/2 subsequent to activation of muscarinic and P2X 7 receptors, which promote increases in Na-K-ATPase turnover, but not upon epidermal growth factor receptor activation. These results suggest that carbachol-initiated AMPK activation can produce a negative feedback on ERK1/2 signaling in response to submaximal muscarinic receptor activation and that increases in fluid secretion can modulate receptor-initiated signaling events indirectly by producing ion transport-dependent decreases in ATP.
adenosine 5'-triphosphatase; calmodulin-dependent protein kinase kinase; 5-aminoimidazole-4-carboxamide-1-β- D -ribofuranoside; carbachol; 2',3'- O -(4-benzoylbenzoyl)adenosine 5'-triphosphate
Address for reprint requests and other correspondence: S. P. Soltoff, Beth Israel Deaconess Medical Center, New Research Bldg. Rm. 1030-J, 77 Ave. Louis Pasteur, Boston, MA 02111 (e-mail: ssoltoff{at}bidmc.harvard |
---|---|
ISSN: | 0363-6143 1522-1563 |
DOI: | 10.1152/ajpcell.00140.2008 |